adalimumab

CHEBI:CHEBI_749245

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
Adalimumab
brand_name
Adalimumab-aacf
brand_name_base
Adalimumab-aacf
dosage_form
LIQUID
product_type
BULK INGREDIENT
listing_expiration_date
20241231
marketing_start_date
20230702
marketing_category
BULK INGREDIENT
application_number
BLA125057
labeler_name
Cordavis Limited
product_ndc
0074-0124
spl_id
22f0af81-8aaa-e1e2-e063-6394a90add0e
pharm_class
Monoclonal [CS]
active_ingredient_strength
95.5 kg/95.5L
active_ingredient_name
ADALIMUMAB-BWWD
unii
FYS6T7F842
nui
M0001357
pharm_class_epc
Tumor Necrosis Factor Blocker [EPC]
pharm_class_moa
Tumor Necrosis Factor Receptor Blocking Activity [MoA]
pharm_class_cs
Antibodies, Monoclonal [CS]
spl_set_id
2488b0bc-7b8f-4cc8-91ea-48e7ea5e8915
upc
0365219610021
rxcui
2668486
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
route
SUBCUTANEOUS
package_ndc
0074-0124-74
package_description
1 KIT in 1 CARTON (0074-0124-74) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET
package_marketing_start_date
19-SEP-19
manufacturer_name
Cordavis Limited